For the fiscal fourth quarter ending March 31, 2025, PetMed Express (PETS, Financial) anticipates net sales to fall between $51.1 million and $53.1 million, a decline from $66.5 million during the same period the previous year. The company also projects a net loss ranging between $9.9 million and $10.4 million, a greater loss compared to the $5.0 million net loss reported in the prior year. This widening loss includes a $6.4 million tax expense impact from establishing a valuation allowance on the company's net deferred tax assets. These financial projections indicate significant challenges faced by PETS in maintaining its sales and profit margins.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for PetMed Express Inc (PETS, Financial) is $3.60 with a high estimate of $4.00 and a low estimate of $3.20. The average target implies an upside of 0.84% from the current price of $3.57. More detailed estimate data can be found on the PetMed Express Inc (PETS) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, PetMed Express Inc's (PETS, Financial) average brokerage recommendation is currently 3.5, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for PetMed Express Inc (PETS, Financial) in one year is $9.96, suggesting a upside of 178.99% from the current price of $3.57. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the PetMed Express Inc (PETS) Summary page.
